Journal of International Oncology ›› 2023, Vol. 50 ›› Issue (11): 655-660.doi: 10.3760/cma.j.cn371439-20230704-00124
• Original Articles • Previous Articles Next Articles
Chen Yu, Xu Hua, Liu Hai, Chen Shixin()
Received:
2023-07-04
Revised:
2023-10-30
Online:
2023-11-08
Published:
2024-01-11
Contact:
Chen Shixin
E-mail:1724035899@qq.com
Chen Yu, Xu Hua, Liu Hai, Chen Shixin. Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660.
"
项目 | 非浸润性腺癌组(n=144) | 浸润性腺癌组(n=73) | t/χ2值 | P值 |
---|---|---|---|---|
结节位置 | ||||
左肺上叶 | 51(35.42) | 22(30.14) | ||
左肺下叶 | 14(9.72) | 9(12.33) | ||
右肺上叶 | 54(37.50) | 25(34.25) | 1.77 | 0.779 |
右肺中叶 | 8(5.56) | 5(6.85) | ||
右肺下叶 | 17(11.81) | 12(16.44) | ||
CT影像学参数指标 | ||||
结节最大径(cm) | 1.19±0.37 | 1.29±0.60 | -1.51 | 0.132 |
结节最小径(cm) | 0.81±0.13 | 0.84±0.14 | -1.57 | 0.119 |
结节质量(g) | 0.23±0.05 | 0.25±0.12 | -1.73 | 0.085 |
形态不规则 | 34(23.61) | 26(35.62) | 3.49 | 0.062 |
边界清晰 | 90(62.50) | 48(65.75) | 0.22 | 0.638 |
分叶征 | 21(14.58) | 13(17.81) | 0.38 | 0.537 |
毛刺征 | 8(5.56) | 25(34.25) | 30.93 | <0.001 |
空泡征 | 37(25.69) | 28(38.36) | 3.70 | 0.054 |
空气支气管征 | 18(12.50) | 49(67.12) | 67.72 | <0.001 |
内部血管征 | 27(18.75) | 68(93.15) | 108.95 | <0.001 |
胸膜凹陷征 | 21(14.58) | 12(16.44) | 0.13 | 0.719 |
瘤肺界面模糊征 | 29(20.14) | 17(23.29) | 0.29 | 0.592 |
结节平扫最大CT值(HU) | -592.79±86.47 | -527.82±72.95 | -5.50 | <0.001 |
结节动脉期CT值(HU) | -553.98±63.15 | -538.21±67.23 | -1.70 | 0.090 |
结节静脉期CT值(HU) | -535.04±72.36 | -528.12±63.54 | -0.69 | 0.489 |
[1] |
Kim YW, Kwon BS, Lim SY, et al. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening[J]. Thorax, 2021, 76(10): 980-988. DOI: 10.1136/thoraxjnl-2020-215107.
pmid: 33859050 |
[2] |
Mei X, Wang R, Yang W, et al. Predicting malignancy of pulmonary ground-glass nodules and their invasiveness by random forest[J]. J Thorac Dis, 2018, 10(1): 458-463. DOI: 10.21037/jtd.2018.01.88.
pmid: 29600078 |
[3] |
Yu Z, Xu C, Zhang Y, et al. A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis[J]. BMC Med Imaging, 2022, 22(1): 133. DOI: 10.1186/s12880-022-00862-x.
pmid: 35896975 |
[4] | World Health Organization. WHO classification of tumours online[EB/OL]. [2021-06-10]. https://tumourclassification.iarc.who.int/. |
[5] | 方三高, 陈真伟, 魏建国. 2021年第5版WHO胸部肿瘤分类[J]. 诊断病理学杂志, 2021, 28(7):591-593,607.DOI:10.3969/j.issn.1007-8096.2021.07.019. |
[6] | 闵旭红, 宋奇隆, 余永强, 等. 三维CT定量联合定性参数的logistic回归模型对纯磨玻璃结节侵袭程度的临床预测价值[J]. 中华放射学杂志, 2021, 55(1): 34-39. DOI: 10.3760/cma.j.cn112149-20200318-00416. |
[7] | 刘莉, 吴宁, 周丽娜, 等. 亚实性结节血管及支气管异常与肺腺癌类病变侵袭性的相关性分析[J]. 中华放射学杂志, 2019, 53(11): 987-991. DOI: 10.3760/cma.j.issn.1005?1201.2019.11.011. |
[8] |
She Y, Zhang L, Zhu H, et al. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules[J]. Eur Radiol, 2018, 28(12): 5121-5128. DOI: 10.1007/s00330-018-5509-9.
pmid: 29869172 |
[9] | Chu ZG, Li WJ, Fu BJ, et al. CT characteristics for predicting invasiveness in pulmonary pure ground-glass nodules[J]. AJR Am J Roentgenol, 2020, 215(2): 351-358. DOI: 10.2214/AJR.19.22381. |
[10] |
Hu F, Huang H, Jiang Y, et al. Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model[J]. J Thorac Dis, 2021, 13(9): 5383-5394. DOI: 10.21037/jtd-21-786.
pmid: 34659805 |
[11] | Li Y, Liu J, Yang X, et al. Prediction of invasive adenocarcinomas manifesting as pure ground-glass nodules based on radiomic signature of low-dose CT in lung cancer screening[J]. Br J Radiol, 2022, 95(1133): 20211048. DOI: 10.1259/bjr.20211048. |
[12] | Zhan Y, Peng X, Shan F, et al. Attenuation and morphologic characteristics distinguishing a ground-glass nodule measuring 5-10 mm in diameter as invasive lung adenocarcinoma on thin-slice CT[J]. AJR Am J Roentgenol, 2019, 213(4): W162-W170. DOI: 10.2214/AJR.18.21008. |
[13] |
Kitazawa S, Saeki Y, Kobayashi N, et al. Three-dimensional mean CT attenuation value of pure and part-solid ground-glass lung nodules may predict invasiveness in early adenocarcinoma[J]. Clin Radiol, 2019, 74(12): 944-949. DOI: 10.1016/j.crad.2019.09.130.
pmid: 31630766 |
[14] | Yang HH, Lv YL, Fan XH, et al. Factors distinguishing invasive from pre-invasive adenocarcinoma presenting as pure ground glass pulmonary nodules[J]. Radiat Oncol, 2020, 15(1): 186. DOI: 10.1186/s13014-020-01628-x. |
[15] | Kao TN, Hsieh MS, Chen LW, et al. CT-based radiomic analysis for preoperative prediction of tumor invasiveness in lung adenocarcinoma presenting as pure ground-glass nodule[J]. Cancers (Basel), 2022, 14(23): 5888. DOI: 10.3390/cancers14235888. |
[16] |
Xu F, Zhu W, Shen Y, et al. Radiomic-based quantitative CT analysis of pure ground-glass nodules to predict the invasiveness of lung adenocarcinoma[J]. Front Oncol, 2020, 10: 872. DOI: 10.3389/fonc.2020.00872.
pmid: 32850301 |
[17] |
Yagi T, Yamazaki M, Ohashi R, et al. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma[J]. Jpn J Radiol, 2018, 36(2): 113-121. DOI: 10.1007/s11604-017-0711-2.
pmid: 29273964 |
[18] | Xiong Z, Jiang Y, Tian D, et al. Radiomics for identifying lung adenocarcinomas with predominant lepidic growth manifesting as large pure ground-glass nodules on CT images[J]. PLoS One, 2022, 17(6): e0269356. DOI: 10.1371/journal.pone.0269356. |
[19] | 李孜垚, 梁绍钦, 赵振伶, 等. Logistic回归预测模型联合炎症标志物对尿毒症血液透析患者并发感染的预测价值[J]. 分子诊断与治疗杂志, 2022, 14(1): 116-119, 123. DOI: 10.3969/j.issn.1674-6929.2022.01.028. |
[20] | 张恒, 刘吉兵, 于永梅, 等. 肺纯磨玻璃结节瘤内及瘤周影像组学联合临床因素对病理分型预测价值探讨[J]. 中华肿瘤防治杂志, 2022, 29(7):508-515,522. DOI:10.16073/j.cnki.cjcpt.2022.07.10. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[3] | Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng. Imaging diagnosis, pathological upgrade, and imaging technology progress of ductal carcinoma in situ of the breast [J]. Journal of International Oncology, 2024, 51(3): 166-169. |
[4] | He Jiahui, Hu Qinyong. Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data [J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[5] | Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng. Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection [J]. Journal of International Oncology, 2023, 50(12): 711-716. |
[6] | Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun. Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model [J]. Journal of International Oncology, 2022, 49(9): 532-536. |
[7] | Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying. Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses [J]. Journal of International Oncology, 2022, 49(8): 459-463. |
[8] | Cai Gangxiang, Li Jing, Xu Bin. Advances in neoadjuvant immunotherapy for lung cancer [J]. Journal of International Oncology, 2022, 49(6): 366-370. |
[9] | Zhang Jingxian, Yi Dan, Li Xiaojiang. Application of antibody-drug conjugates in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(5): 296-301. |
[10] | Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei. Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer [J]. Journal of International Oncology, 2022, 49(4): 247-251. |
[11] | Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu. Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(3): 140-145. |
[12] | Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming. Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(2): 111-115. |
[13] | Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83. |
[14] | Huang Huayu, Song Qibin, Gong Hongyun, Song Jia. Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy [J]. Journal of International Oncology, 2022, 49(12): 718-723. |
[15] | Zhang Hongjiao, Jiang Jie, Huang Wei. Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis [J]. Journal of International Oncology, 2022, 49(1): 51-55. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||